Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,158
Award facts
- Contract value 100% obligated
- $3,158.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $3,158.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on October 31, 2025, with an ultimate completion date of November 3, 2025, requires fulfillment at the contractor's Park Ridge location. DMS Pharmaceutical Group was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors for pharmaceutical supply to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under the PPV-G GEN V program (contract SPE2DR) with a ceiling value of $499,999,999 and term extending through December 31, 2036, positioning the company as a critical supplier of pharmaceuticals and medical consumables to military healthcare operations globally. The company's extensive product portfolio includes branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical supplies spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals. The contractor has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with no subcontractor relationships identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FENWY?
SPE2DU26FENWY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DU26FENWY worth?
The government has obligated $3,158 on SPE2DU26FENWY.
Is contract SPE2DU26FENWY an order under another contract?
Yes. SPE2DU26FENWY is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWY competed?
The extent of competition for SPE2DU26FENWY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award